Cargando…
Oral Administration and Intralesional Injection of Hyaluronic Acid Versus Intralesional Injection Alone in Peyronie's Disease: Results from a Phase III Study
PURPOSE: The aim of this study was to compare the effect of combined oral administration and intralesional injection of hyaluronic acid (HA) with intralesional injections alone, in patients with early onset of Peyronie's disease (PD). MATERIALS AND METHODS: For this prospective, randomized phas...
Autores principales: | Cai, Tommaso, Tiscione, Daniele, Favilla, Vincenzo, Puglisi, Marco, Palumbo, Fabrizio, Zucchi, Alessandro, Malossini, Gianni, Palmieri, Alessandro, Bjerklund Johansen, Truls E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Sexual Medicine and Andrology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255397/ https://www.ncbi.nlm.nih.gov/pubmed/33151042 http://dx.doi.org/10.5534/wjmh.200048 |
Ejemplares similares
-
Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie's Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study
por: Zucchi, Alessandro, et al.
Publicado: (2016) -
Collagenase clostridium histolyticum intralesional injections for the treatment of Peyronie’s disease: a safety profile
por: Yan, Sylvia, et al.
Publicado: (2017) -
Complications and other concerns with intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Levine, Laurence A.
Publicado: (2017) -
Tadalafil once daily and intralesional verapamil injection: A new therapeutic direction in Peyronie's disease
por: Dell’Atti, Lucio
Publicado: (2015) -
Expanded Utilization of Intralesional Therapies for Treatment of Peyronie’s Disease
por: Khooblall, Prajit, et al.
Publicado: (2023)